Craig Portell, MD, Oncology, Charlottesville, VA, University of Virginia Medical Center

CraigAnthonyPortellMD

Oncology Charlottesville, VA

Hematologic Oncology

Associate Professor of Medicine, Division of Hematology/Oncology, University of Virginia

Dr. Portell is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Portell's full profile

Already have an account?

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFELLOWSHIP
  • Loyola University
    Loyola UniversityRESIDENCY
  • Saint Louis University School of Medicine
    Saint Louis University School of MedicineMEDICAL_SCHOOL

Certifications & Licensure

  • VA State Medical License
    VA State Medical License 2013 - 2022
  • OH State Medical License
    OH State Medical License 2010 - 2014
  • IL State Medical License
    IL State Medical License 2006 - 2011
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)
    Craig A. Portell, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-Worl...
    Craig A. Portell, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Fitness and Anthracycline Use in Front-Line Therapy for Older Patients with Classical Hodgkin Lymphoma: A US Multi-Center Retrospective Analysis
    Craig A. Portell, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Multi-Institution Phase I/Ib Continual Re-Assessment Study to Identify the Optimal Dose of of Ibrutinib (IBR) and Venetoclax (VEN) in Relapsed or Refractory Mantle Cel... 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019

Professional Memberships

Hospital Affiliations